e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Models of disease and drug actions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Neutraligands of CXCL12: Anti-inflammatory activity in an allergic model of asthma
F. Daubeuf, M. Hachet-Haas, V. Gasparik, P. Gizzi, F. Rohmer, J. Haiech, D. Bonnet, M. Hibert, J. L. Galzi, N. Frossard (Illkirch, France)
Source:
Annual Congress 2011 - Models of disease and drug actions
Session:
Models of disease and drug actions
Session type:
Poster Discussion
Number:
1786
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Daubeuf, M. Hachet-Haas, V. Gasparik, P. Gizzi, F. Rohmer, J. Haiech, D. Bonnet, M. Hibert, J. L. Galzi, N. Frossard (Illkirch, France). Neutraligands of CXCL12: Anti-inflammatory activity in an allergic model of asthma. Eur Respir J 2011; 38: Suppl. 55, 1786
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Anti-inflammatory and anti-asthmatic effects of resolvin E1 in a mouse model of allergic asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008
Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma.
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Aerobic training reverses the inhibition in the expression of glucocorticoid receptors and decreases the Th2 allergic inflammation in asthma model
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Stimulatory behaviours of human pulmonary
i
nkt cells in allergic asthma
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
Utility of Interleukin-5 in phenotyping allergic versus non allergic asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Identifying eosinophil subsets in a mouse model of pollutant-aggravated allergic asthma
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
Clinical relevance of anti-inflammatory treatment of rhinitis for the course and prognosis of allergic bronchial asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007
A role of fungal extracts on allergic airway inflammation in the ovalbumin-induced asthma model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Adjuvant and anti-inflammatory properties of cigarette smoke in murine models of allergic airways inflammation
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008
Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 433s
Year: 2006
TNFAIP3/A20 expression in allergic asthma
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Protective effect of thrombomodulin in a murine model of allergen-induced asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status?
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Analysis of mucus production in mouse models of allergic asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept